The construction of the national stem cell bank is of great significance.

"In recent years, a number of foreign-funded enterprises in China to carry out stem cell collection business, resulting in a large number of stem cell resources lost serious situation, which poses a great threat to the safety of the people's lives and resources, resulting in economic losses are also incalculable.
" CPPCC National Committee member, Guangzhou Celera Stem Cell Technology Co., Ltd. Chairman Chen Haijia recently proposed that the National Development and Reform Commission lead, jointly with relevant departments, to build a national stem cell bank.
Chen Haijia believes that stem cell resources are important strategic resources of the country, involving national security, nationality, nuclear-related, aerospace and many other special fields, how to safely and effectively preserve China's special, unique and rare human biological resources, to promote China's population health, maintain population safety, control major diseases and promote medical innovation plays an important role.
Science and Technology Daily reporter learned that stem cell technology has been widely used in diabetes, nervous system injury, autoimmune diseases and other major refractive diseases, and achieved remarkable results.
However, so far, China has not yet a standardized management, standard synws of a unified national stem cell bank, resulting in China's cell resources are facing a large number of outflow, loss and other major risks, but also restrictthe dislocation of China's stem cell research results industrialization.
Chen Haijia also suggested that the national stem cell bank be located in Guangzhou, and in Guangdong to establish medical, educational, rehabilitation and old-age as one of the national stem cell resource storage and conversion base.
" to build the world's largest stem cell storage capacity, more than 50 million intelligent national stem cell bank and related supporting industrial transformation facilities.
" he suggested establishing the world's first stem cell research institute with nuclear-related and special population research, Chinese national population research, genetics and assisted reproduction, and the world's first specialized stem cell hospital with nuclear-related, tumor prevention and control, chronic disease management and medical care.
.